Software firm razorblue has developed a new platform for Acculabs Diagnostics which enabled the company to increase the efficiency and capacity of its Covid-19 testing.
The new software has eliminated paperwork and manual administration and links data such as the sample itself, where it has come from, and results post-testing.
As a result, Acculabs Diagnostics has been able to up capacity to thousands of swabs a day and taken on new staff to provide round-the-clock testing.
Jonathan Anderson, Managing Director of North East-based razorblue software, said: “We knew that this was a critical and time-sensitive project. The company handles vast volumes of extremely sensitive data and there was absolutely no room for error.
